Skip to main content
BJS Open logoLink to BJS Open
. 2026 Jun 1;10(3):zrag051. doi: 10.1093/bjsopen/zrag051

Comparative long-term risks of chronic kidney disease and dialysis following conservative treatment, renal artery embolization, or nephrectomy in patients with blunt kidney injuries: retrospective cohort study

Jhih-Ming Tang 1, Ling-Wei Kuo 2,3, Jen-Fu Huang 4,5,6, Chih-Po Hsu 7,8, Chi-Tung Cheng 9,10,✉, Huan-Wu Chen 11,12, Cheng-Hsien Wu 13,14, Yon-Cheong Wong 15,16, Szu-An Chen 17,18, Chia-Cheng Wang 19,20, Yu-San Tee 21,22, Chun-Hsiang Ou Yang 23,24, Chih-Yuan Fu 25,26, Chien-Hung Liao 27,28
PMCID: PMC13224839  PMID: 42224098

Abstract

Background

Long-term changes in renal function following blunt kidney injury (BKI) remain insufficiently studied, particularly in patients who undergo renal artery embolization (RAE). The aim of this study was to clarify the long-term risks of chronic kidney disease (CKD) and dialysis in patients with BKI after unilateral nephrectomy, RAE, or conservative treatment. The hypothesis was that both unilateral nephrectomy and RAE would increase these risks compared with conservative treatment, with RAE posing a lower risk.

Methods

This retrospective cohort study used data from Taiwan’s National Health Insurance Research Database from 2001 to 2019, focusing on patients with BKIs. Outcomes included long-term CKD risks, lifelong dialysis, and all-cause mortality. Inverse probability of treatment weighting was used to minimize confounding.

Results

During the study, 19 013 patients were diagnosed with BKIs; of these, 12 709 were analysed (unilateral nephrectomy, 274 (2.1%); RAE, 510 (4.0%); conservative treatment, 11 925 (93.8%)). The mean(standard deviation) age was 39.7(17.1) years, 69.4% were male, and the mean follow-up duration was 10.7(5.2) years. Compared with conservative treatment, patients undergoing unilateral nephrectomy (subdistribution hazard ratio (SHR) 1.97; 95% confidence interval (c.i.) 1.86 to 2.10) or RAE (SHR 1.17, 95% c.i. 1.09 to 1.26) had a higher risk of CKD. In addition, patients in the nephrectomy and RAE groups had an increased risk of lifelong dialysis, with an SHR of 3.97 (95% c.i. 3.09 to 5.10) and 1.46 (95% c.i. 1.07 to 1.99), respectively. Unilateral nephrectomy was associated with a higher risk of all-cause mortality than RAE and conservative treatment, with hazard ratios of 1.14 (95% c.i. 1.06 to 1.23) and 1.63 (95% c.i. 1.52 to 1.75), respectively.

Conclusions

Patients with BKIs are at higher risk of long-term CKD and potential lifelong dialysis after both unilateral nephrectomy and RAE, with RAE presenting a lower risk than nephrectomy. Patients with BKIs who undergo unilateral nephrectomy or RAE require follow-up to monitor renal function and receive health education on kidney protection.

Keywords: renal preservation, competing risk analysis, end-stage kidney disease, trauma surgery, inverse probability of treatment weighting, abdominal injuries


Using a large, population-based retrospective cohort and inverse probability of treatment weighting, this study compared long-term renal outcomes (chronic kidney disease and dialysis) after conservative treatment, renal artery embolization (RAE), or nephrectomy for blunt kidney injuries. Nephrectomy carried a significantly higher risk of chronic kidney disease and dialysis than both RAE and conservative management, whereas RAE was associated with a greater risk of both than conservative management.

Introduction

Blunt kidney injuries (BKIs) occur in 1–5% of trauma patients, a relatively low incidence attributed to the kidney’s well-protected retroperitoneal position1–5. BKI typically results from high-energy incidents, such as motor vehicle accidents, falls from heights, or direct blows to the flank, where rapid deceleration or direct compression leads to renal parenchymal laceration, subcapsular haematoma, or injury to the renal pedicle6,7. Clinically, BKI presents with a spectrum of signs including flank pain, ecchymosis, and haematuria7,8. Diagnosis relies on clinical suspicion from the mechanism of injury, the presence of either gross or microscopic haematuria, focused assessment with sonography for trauma, or computed tomography in patients with stable haemodynamics5,9,10. Computed tomography is the imaging modality of choice because of its ability to identify injury grade and active bleeding11–13. The American Association for the Surgery of Trauma grading system provides an essential anatomic framework for management, where low-grade injuries (grades I–II) are typically managed conservatively, whereas high-grade injuries (grades III–V) involving deep lacerations, urinary extravasation, or vascular compromise often necessitate interventional radiology or surgical procedures13,14.

Haemodynamic stability is the primary concern in treatment. Non-operative management, including close monitoring, serial blood tests, and renal artery embolization (RAE) as an adjunct to achieve haemostasis, is currently the mainstay of treatment for stable patients13,14. Non-operative management can be attempted in 83–90% of patients with BKIs, with a reported success rate of 94–97%5,15,16. Conversely, for patients who do not respond to resuscitation, prompt surgical exploration is essential13,14. In these critical situations, a nephrectomy may be required17–19. Despite the continued need for surgery in unstable patients, the management of BKI has shifted towards more conservative approaches. This is evidenced by clinical data from Japan and the USA, where nephrectomy rates for BKIs have decreased significantly, coinciding with a marked increase in the use of RAE as a minimally invasive alternative for haemorrhage control20,21.

High-grade renal trauma could lead to a loss of functional reserve in the kidney22–24. Furthermore, patients with BKIs following nephrectomy were found to have a higher long-term risk of CKD and lifelong dialysis25. However, with the growing use of RAE for patients with BKIs, the long-term risks of CKD and the need for lifelong dialysis remain uncertain. A study using the American College of Surgeons Trauma Quality Improvement Program databank revealed that both nephrectomy and RAE were associated with acute kidney injury during the index admission26. Additional evidence concerning the long-term risks following RAE is derived from studies employing serum creatinine measurements and various imaging modalities to evaluate the viability and morphological changes of embolized kidneys over time27–30. Notably, in the absence of a control group, it is challenging to evaluate the long-term risks associated with RAE. Other studies have had a relatively short follow-up period, making it difficult to clearly identify the associated risks31,32.

The aim of the present study was to clarify the long-term risks of CKD and dialysis in patients with BKIs after nephrectomy, RAE, or conservative treatment. The hypothesis was that both nephrectomy and RAE would increase these risks compared with conservative treatment, with RAE posing a lower risk.

Methods

Data source

Taiwan’s National Health Insurance system has been operational for three decades, providing mandatory coverage to over 99% of citizens. The programme supports a broad spectrum of medical costs for various illnesses, with the Taiwan Government acting as the sole payer. A peer review mechanism is in place to validate medical procedures. Moreover, the National Health Insurance includes a catastrophic illness programme that addresses severe health issues, such as major trauma with an injury severity score (ISS) ≥ 16 and end-stage renal disease requiring chronic dialysis. Patients eligible for this programme receive comprehensive coverage, with substantially reduced out-of-pocket expenses. This study used the National Health Insurance Research Database (NHIRD), which gathers claims data for insurance reimbursements. The NHIRD, along with its associated databases, is administered by the Health and Welfare Data Science Centre as a component of the National Health Informatics Project. Additional details about the NHIRD and its validation processes are available elsewhere33–35. This study was approved by the Institutional Review Board of the Chang Gung Medical Foundation (IRB No. 202101615B0), and the requirement for informed consent was waived due to its retrospective nature.

Study design

The data used in the present study spanned from 2001 to 2019. Participants were identified in the NHIRD using specific diagnostic codes for BKI. The International Classification of Diseases (ICD), Ninth Revision, Clinical Modification codes (866.0X; excluding penetrating injury code 866.1X) were used for patients before 31 December 2015, and transitioned to ICD, Tenth Revision, Clinical Modification codes (S37.0X; excluding penetrating injury code S31.6X) thereafter. A comprehensive list of all ICD codes used for participant selection and the identification of co-morbidities is provided in Table S1. Patients with missing demographic data, such as sex and age, and individuals aged < 18 years were excluded from the study. Patients with a history of CKD or those who were receiving chronic dialysis or had undergone nephrectomy, partial nephrectomy, renal transplantation, or renal donation before the trauma or within 1 year of discharge were also excluded. Furthermore, individuals who underwent bilateral nephrectomy or partial nephrectomy during the index admission were ineligible for inclusion. Bilateral nephrectomy was excluded because it necessitates immediate, permanent dialysis, which represents a clinical course distinct from the gradual CKD progression under investigation. Partial nephrectomy was also excluded to minimize potential bias; the NHIRD lacks granular data to quantify the extent of resected parenchyma or the impact of operative factors, such as warm ischaemia time, which significantly affect long-term renal outcomes36,37. Patients with concurrent moderate to severe liver or spleen injuries, as well as unstable pelvic fractures, were excluded owing to inadequate information regarding the site of transarterial embolization38. The exclusion criteria also included trauma-related deaths during the initial hospitalization and patients with < 365 days of follow-up after discharge, including those who died within this period. Eligible patients were classified into three groups based on treatment modality: unilateral nephrectomy, RAE, or conservative treatment.

Measurement of covariates

Basic demographic data, including patient age and sex, were recorded. Injuries associated with the index BKI admission, including traumatic brain injury, spinal cord injury, cardiac and pulmonary injuries, pneumothorax, haemothorax, gastrointestinal injuries, femur fractures, and major trauma with an ISS > 16, were documented. In addition, any co-morbidities (such as hypertension, ischaemic heart disease, congestive heart failure, ischaemic stroke, diabetes, cirrhosis, and chronic obstructive pulmonary disease) were noted. Co-morbidities were considered to be present if there were at least two outpatient diagnoses or a single inpatient diagnosis within the year leading up to the index BKI admission. Bed confinement or paralysis may be associated with a higher risk of mortality39, whereas hypertension is strongly linked to the deterioration of renal function40,41. Therefore, whether patients were confined to bed or were paralysed and had a new diagnosis of hypertension during the first year after discharge was also assessed. The diagnostic accuracy of the ICD codes for the majority of the aforementioned co-morbidities has been previously validated in several studies using the NHIRD, ensuring the reliability of the clinical data35,42.

Outcome definitions

The primary outcomes were the incidence and cumulative risks of newly diagnosed CKD, requirement for lifelong dialysis, and all-cause mortality. To reduce the risk of reverse causality, outcomes were assessed only when they occurred more than 1 year after the index admission43. Details on the causes, dates, and locations of death are available through the Taiwan Death Registry, maintained by the Health and Welfare Data Science Centre. New-onset CKD required two outpatient diagnoses spaced at least 90 days apart44. Chronic dialysis status was verified via the Catastrophic Illness Certificate database, where patients with a Catastrophic Illness Certificate card are exempt from all chronic dialysis costs45. Relevant ICD codes for these diseases are provided in Table S1.

Statistical analysis

To mitigate potential confounding and ensure balanced baseline characteristics among the three study groups (that is, nephrectomy, RAE, and conservative treatment), an inverse probability of treatment weighting (IPTW) approach using propensity scores was applied. The propensity scores were calculated using generalized boosted modelling with 10 000 decision trees46. All covariates were used to compute the propensity scores, as detailed in Table 1. Importantly, the admission date for BKI was factored into the calculation of propensity scores to guarantee comparable potential follow-up durations among the three study groups. The balance of baseline characteristics among the three study groups was assessed before and after applying IPTW, using the maximum absolute standardized difference (MASD) as a measure. Although an MASD < 0.1 is often considered indicative of a negligible imbalance, a threshold of < 0.2 was adopted to represent a non-significant difference for studies involving multiple treatment groups, a criterion supported by established literature for propensity score-based analyses46 . As a result, all outcome comparisons between the study groups were performed on the IPTW-adjusted cohort. A Cox proportional hazards model was used to evaluate the risk of all-cause mortality among the three groups, whereas the Fine–Gray subdistribution hazard model was used to analyse kidney outcomes, treating all-cause mortality as a competing risk.

Table 1.

Baseline demographics and characteristics of patients between different treatments for blunt kidney injuries before inverse probability of treatment weighting

Total (n = 12 709) Nephrectomy (n = 274) RAE (n = 510) Conservative (n = 11 925) MASD
Demographics
 Age (years), mean(s.d.) 39.7(17.1) 38.5(17.7) 38.9(17.4) 39.8(17.0) 0.07
 Age grouping
  < 30 years 4778 (37.6%) 117 (42.7%) 220 (43.1%) 4441 (37.2%) 0.12
  30–49 years 4399 (34.6%) 86 (31.4%) 148 (29.0%) 4165 (34.9%) 0.13
  50–64 years 2345 (18.5%) 42 (15.3%) 97 (19.0%) 2206 (18.5%) 0.10
  ≥ 65 years 1187 (9.3%) 29 (10.6%) 45 (8.8%) 1113 (9.3%) 0.06
 Sex 0.11
  Male 8825 (69.4%) 203 (74.1%) 364 (71.4%) 8258 (69.2%)
  Female 3884 (30.6%) 71 (25.9%) 146 (28.6%) 3667 (30.8%)
Associated injuries
 Traumatic brain injury 473 (3.7%) 14 (5.1%) 43 (8.4%) 416 (3.5%) 0.21
 Spinal cord injury 120 (0.9%) 0 (0.0%) 5 (1.0%) 115 (1.0%) 0.14
 Injury to heart and lung 470 (3.7%) 13 (4.7%) 43 (8.4%) 414 (3.5%) 0.21
 PTX and HTX 1334 (10.5%) 55 (20.1%) 120 (23.5%) 1159 (9.7%) 0.38
 GI tract injury 361 (2.8%) 41 (15.0%) 19 (3.7%) 301 (2.5%) 0.45
 Femur fracture 281 (2.2%) 11 (4.0%) 19 (3.7%) 251 (2.1%) 0.11
 Major trauma* 912 (7.2%) 105 (38.3%) 197 (38.6%) 610 (5.1%) 0.89
Co-morbidities
 Hypertension 1634 (12.9%) 34 (12.4%) 67 (13.1%) 1533 (12.9%) 0.02
 Ischaemic heart disease 371 (2.9%) 8 (2.9%) 13 (2.6%) 350 (2.9%) 0.02
 Congestive heart failure 86 (0.7%) 3 (1.1%) 3 (0.6%) 80 (0.7%) 0.06
 Ischaemic stroke 251 (2.0%) 1 (0.4%) 9 (1.8%) 241 (2.0%) 0.15
 Diabetes 192 (1.5%) 4 (1.5%) 12 (2.4%) 176 (1.5%) 0.07
 Cirrhosis 108 (0.9%) 0 (0.0%) 8 (1.6%) 100 (0.8%) 0.18
 COPD 250 (2.0%) 5 (1.8%) 5 (1.0%) 240 (2.0%) 0.08
Confined to bed 100 (0.8%) 6 (2.2%) 8 (1.6%) 86 (0.7%) 0.12
Hypertension diagnosed during the first year of follow-up 1776 (14.0%) 31 (11.3%) 89 (17.5%) 1656 (13.9%) 0.18

Values are n (%) unless otherwise stated. *Major trauma was defined as an injury severity score ≥ 16. RAE, renal artery embolization; MASD, maximum absolute standardized difference; s.d., standard deviation; PTX, pneumothorax; HTX, haemothorax; GI, gastrointestinal; COPD, chronic obstructive pulmonary disease.

Apart from missing demographic data (that is, age and sex), no additional missing values were identified for the covariates or outcomes. Two-tailed P < 0.050 was deemed statistically significant. All statistical analyses were conducted using R version 4.2.1 (R Foundation for Statistical Computing, Vienna, Austria) and SAS® version 9.4 (SAS Institute, Cary, NC, USA).

Results

Patient selection and temporal trends

Over the study period, 19 013 patients were diagnosed with BKIs. Of these patients, 12 709 were considered eligible for analysis in the present study: 274 patients (2.1%) who underwent nephrectomy, 510 patients (4.0%) who underwent RAE, and 11 925 patients (93.8%) who were treated conservatively. RAE has emerged as the primary haemostatic procedure for BKIs over the years, as disclosed in Fig. 1a. The inclusion process for the study is shown in Fig. 1b.

Fig. 1.

Figure 1a is a stacked bar chart showing the increasing annual trend of renal artery embolization and the decreasing trend of nephrectomy for blunt kidney injuries. Figure 1b is a flowchart detailing the study’s patient selection process, moving from 19 013 initial cases to a final analyzed cohort of 12 709 patients.

Temporal trends in the treatment of blunt kidney injuries throughout the study period and flow chart of patient selection

a Trends in the treatment of blunt kidney injuries over the study period. b Flow chart of patient selection, detailing inclusion and exclusion criteria. RAE, renal artery embolization.

Baseline characteristics

As indicated in Table 1, the study group was relatively young, with a mean(standard deviation (s.d.)) age of 39.7(17.1) years, and was predominantly male (69.4%). The incidence of traumatic brain injury was higher in the RAE than nephrectomy and conservative treatment groups (8.4 versus 5.1 and 3.5%, respectively; MASD = 0.21), as was the incidence of haemopneumothorax (23.5 versus 20.1 and 9.7%, respectively; MASD = 0.38). Conversely, patients in the nephrectomy group were more likely to have gastrointestinal tract injuries than those in the RAE or conservative treatment groups (15.0 versus 3.7 and 2.5%, respectively; MASD = 0.45). The rate of major trauma, defined as an ISS ≥ 16, in the nephrectomy, RAE, and conservative treatment groups was 38.3%, 38.6%, and 5.1%, respectively (MASD = 0.89). The prevalence of co-morbidities was similar among the three study groups. The overall mean(s.d.) follow-up duration was 10.7(5.2) years. Before IPTW, the mean(s.d.) follow-up duration in the nephrectomy, RAE, and conservative treatment groups was 10.3(5.1), 7.1(4.3), and 10.8(5.2) years, respectively. After applying IPTW, all baseline characteristics, including the follow-up duration, in three groups were comparable, with all MASD values below 0.20 (Table S2).

Risk of CKD

Table 2 presents long-term follow-up outcomes related to CKD for the three study groups. The risk of CKD was higher in both the nephrectomy (subdistribution hazard ratio (SHR) 1.97; 95% confidence interval (c.i.) 1.86 to 2.10) and RAE (SHR 1.17, 95% c.i. 1.09 to 1.26) groups than in the conservative treatment group. Patients who underwent nephrectomy also had a higher risk of CKD than those who underwent RAE (SHR 1.68; 95% c.i. 1.58 to 1.80). Figure 2a illustrates the long-term risk of CKD across the three groups. Because group differences began to diverge around the fourth to fifth years of follow-up, a landmark analysis was conducted in the fourth year of follow-up (Fig. 2b). This landmark analysis revealed no significant difference in CKD risk between the nephrectomy and RAE groups during the first 4 years of follow-up. However, the observed difference in CKD risk between the groups persisted beyond the fourth year of follow-up.

Table 2.

Follow-up outcomes of patients between different treatments for blunt kidney injuries in the IPTW-adjusted cohort

Event rate (%) Incidence rate (no. of events/10 000 person-years) HR/SHR*
RAE Nephrectomy
Chronic kidney disease
 Conservative 14.1 141.0 (134.5, 147.5) 1.17 (1.09, 1.26)† 1.97 (1.86, 2.10)†
 RAE 15.4 174.2 (165.0, 183.3) 1.68 (1.58, 1.80)†
 Nephrectomy 26.2 283.0 (271.6, 294.3)
Chronic dialysis
 Conservative 0.6 6.0 (4.7, 7.3) 1.46 (1.07, 1.99)† 3.97 (3.09, 5.10)†
 RAE 0.9 8.8 (6.9, 10.8) 2.71 (2.10, 3.50)†
 Nephrectomy 2.6 24.6 (21.5, 27.7)
All-cause death
 Conservative 10.7 100.5 (95.1, 105.8) 1.43 (1.33, 1.55)† 1.63 (1.52, 1.75)†
 RAE 13.7 140.9 (133.0, 148.7) 1.14 (1.06, 1.23)†
 Nephrectomy 17.7 163.0 (155.1, 170.9)

Values in parentheses are 95% confidence intervals. After IPTW, the number of weighted patients in the conservative, nephrectomy, and RAE groups was 12 670.8, 9030.3, and 9149.6, respectively. *Column versus row. IPTW, inverse probability of treatment weighting; HR, hazard ratio; SHR, subdistribution hazard ratio; RAE, renal artery embolization. †P < 0.050.

Fig. 2.

Figure 2a is a cumulative incidence plot showing that patients undergoing nephrectomy or RAE have a higher long-term risk of CKD than those receiving conservative treatment over 18 years. Figure 2b is a landmark analysis at 4 years, demonstrating that the significant increase in CKD risk for the nephrectomy and RAE groups primarily manifests and diverges from the conservative group after a four-year latency period.

Cumulative event rates of CKD among different treatment groups after inverse probability of treatment weighting

Cumulative CKD event rates a overall during the entire follow-up period and b in the landmark analysis (at 4 years of follow-up). *Values in parentheses are 95% confidence intervals. CKD, chronic kidney disease; RAE, renal artery embolization; SHR, subdistribution hazard ratio.

Lifelong dialysis

Patients with BKIs who underwent nephrectomy (SHR 3.97; 95% c.i. 3.09 to 5.10) and those in the RAE group (SHR 1.46; 95% c.i. 1.07 to 1.99) had a higher risk of lifelong dialysis than those who underwent conservative treatment. The risk of lifelong dialysis was higher in the nephrectomy than RAE group (SHR 2.71; 95% c.i. 2.10 to 3.50), as shown in Fig. 3a. A 4-year latency in the development of lifelong dialysis was also noted (Fig. 3b). In the first 4 years after the index admission, the risk of lifelong dialysis was similar among the three study groups. However, the risk of lifelong dialysis started to diverge among the treatment groups in the fourth year of follow-up. Notably, patients who underwent unilateral nephrectomy had a four-fold increase in the risk of lifelong dialysis after this timepoint (SHR 4.23; 95% c.i. 3.26 to 5.49) compared with the conservative group.

Fig. 3.

Figure 3a is a cumulative incidence plot showing that patients who underwent nephrectomy or RAE have a significantly higher long-term risk of chronic dialysis compared to those treated conservatively. Figure 3b is a landmark analysis at 4 years, highlighting that this increased risk for dialysis in the nephrectomy and RAE groups is a long-term consequence that persists and widens many years after the initial injury.

Cumulative event rates of the need for lifelong dialysis among different treatment groups after inverse probability of treatment weighting

Chronic dialysis event rates a overall during the entire follow-up period and b in the landmark analysis (at 4 years of follow-up). *Values in parentheses are 95% confidence intervals. RAE, renal artery embolization; SHR, subdistribution hazard ratio.

All-cause mortality

The risk of all-cause mortality was higher in patients who underwent nephrectomy than in those who underwent RAE (hazard ratio (HR) 1.14; 95% c.i. 1.06 to 1.23) or conservative treatment (HR 1.63; 95% c.i. 1.52 to 1.75). The mortality risk was higher in the RAE group than in the conservative treatment group (HR 1.43; 95% c.i. 1.33 to 1.55; Fig. 4). The cumulative mortality and incidence rates are detailed in Table 2.

Fig. 4.

A cumulative mortality plot illustrating the long-term risk of all-cause mortality over an 18-year follow-up period for patients with blunt kidney injuries. The plot compares three treatment cohorts: conservative treatment, renal artery embolization (RAE), and unilateral nephrectomy. The curves demonstrate that the unilateral nephrectomy group has the highest cumulative risk of death, followed by the RAE group, while the conservative treatment group consistently maintains the lowest mortality risk throughout the follow-up duration.

Cumulative event rates of all-cause mortality among different treatment groups after inverse probability of treatment weighting

*Values in parentheses are 95% confidence intervals. RAE, renal artery embolization.

Discussion

The present study revealed that both unilateral nephrectomy and RAE significantly increased the long-term risk of CKD and the need for lifelong dialysis; however, RAE had a comparatively smaller impact on adverse renal outcomes. In addition, patients who underwent nephrectomy had a higher risk of all-cause mortality. RAE preserves renal function effectively and should be considered the preferred method for patients with BKIs experiencing active bleeding when clinically appropriate.

RAE has assumed an increasingly prominent role in the management of BKIs. In Japan, the use of RAE increased markedly from 25.9% in 2004–2006 to 35.5% in 2016–2018, whereas the nephrectomy rate declined from 5.3 to 2.4% over the same period21. Similarly, in the USA, the proportion of RAEs increased markedly from 1.4% in 2002 to 53.3% in 2012, with the nephrectomy rate decreasing from 8.2 to 2.1% over the same time frame45–51. Advances in resuscitation and critical care have enabled clinicians to stabilize patients more effectively, thereby reducing the need for nephrectomies. Furthermore, the increased availability of interventional radiologists, along with the maturation and improved accessibility of techniques, has contributed significantly to these trends. However, the rise in RAE use far outpaces the decline in nephrectomy rates, suggesting that some patients who could have been successfully managed with conservative treatment may have undergone unnecessary RAE. According to the present study, conservative treatment remains the approach associated with the fewest long-term side effects, and clinicians should base their treatment decisions on appropriate indications rather than indiscriminate intervention.

The association between unilateral nephrectomy and the long-term risk of CKD or the need for lifelong dialysis remains controversial. Although numerous studies47–53 reported a non-significant relationship between unilateral nephrectomy and the long-term development of CKD and subsequent lifelong dialysis, these studies did observe lower creatinine clearance rates and increased proteinuria over time. Nevertheless, most of these studies had limited sample sizes to detect risks or did not compare the risks following unilateral nephrectomy to a control group. Cozzi et al.54 conducted a review of 22 papers that suggested unilateral nephrectomy during childhood increases the risk of lower renal function, consistent with the findings of the present study. Notably, most studies focused on oncological or donor nephrectomy, and research specifically addressing patients with BKI is scarce. The present study used a nationwide population-based data set to provide real-world data to gain a better understanding of this issue.

A single-vessel system supplies the kidneys; therefore, RAE can lead to parenchymal ischaemia and a loss of functional reserve. Imaging studies conducted 6–12 months after the procedure to evaluate parenchymal ischaemia revealed a mean parenchymal perfusion deficit of 5–6%29. In another study, after a mean follow-up of 4.6 years, radioisotope renography indicated functional improvement in the embolized renal units31. Despite the evidence from imaging studies, there has been no long-term follow-up or assessment of the risks associated with RAE for BKIs. Only one study reported a mean follow-up of 2.7 years, finding no changes in renal function among patients with grade 5 kidney injuries following RAE, based on questionnaire responses31. The present study provides insights into the long-term prognosis for patients with BKIs who underwent RAE.

BKIs can lead to a loss of renal function, particularly in cases of high-grade or vascular injury53. There is also a loss of functional renal reserve, which is necessary for haemostasis and life-saving interventions, after RAE and nephrectomy. Brenner55 proposed that the permanent loss of nephron units leads to structural and functional adaptations in the surviving nephrons, which initially compensate for this loss through hypertrophy and elevated intraglomerular pressures. However, hyperfiltration in the remaining nephrons can damage the glomeruli and contribute to the deterioration of renal function56. This may explain the findings of the present study, namely that both nephrectomy and RAE were associated with long-term adverse renal outcomes after a latency period of approximately 4 years.

Compared with patients with BKIs who underwent conservative treatment, those who underwent unilateral nephrectomy had a higher long-term risk of all-cause mortality, whereas the RAE group had a comparatively lower risk. A detailed analysis of the causes of death was not conducted in the present study. Several studies57–59 have reported that unilateral nephrectomy and the resulting chronic renal insufficiency are associated with an increased risk of cardiovascular disease and mortality, which supports the findings of the present study.

Life-saving measures remain the top priority in managing BKIs. Clinicians should adhere to current management guidelines to maximize survival and long-term renal outcomes. With RAE and nephrectomy performed for haemostasis and life-saving purposes, patients must be informed about the long-term risks of CKD and the possibility of requiring lifelong dialysis. Health education on kidney protection should include avoiding nephrotoxic agents, quitting smoking, and controlling blood pressure and blood sugar levels60,61. Clinicians should also be aware that patients with BKIs who have undergone unilateral nephrectomy have an increased risk of all-cause mortality.

This study has some limitations. First, as a retrospective cohort study, the results should be interpreted as showing associations rather than establishing causality. Second, the nature of a database study means that certain detailed information may be lacking. For example, the NHIRD lacks granular clinical information, such as the American Association for the Surgery of Trauma renal injury grade and acute physiological data including vital signs (for example, blood pressure and heart rate) and body mass index (obesity). Although major trauma (ISS ≥ 16) and multiple chronic co-morbidities were adjusted for to minimize bias, the potential for residual confounding related to the specific severity of the renal injury or baseline physiological reserve cannot be entirely ruled out. Moreover, information on the exact location of transarterial embolization was not available, and the approach of identifying patients undergoing RAE by excluding other sites could have introduced bias. Furthermore, the absence of patients’ laboratory data prevented assessment of the severity of renal dysfunction. Third, the exclusion process in this study may have introduced a risk of bias into the findings. In addition, because the findings are based on the Taiwanese population and treatment practices, they may not be directly generalizable to other populations. A future prospective study incorporating long-term clinical follow-up, laboratory tests, and imaging results may be necessary to draw more definitive conclusions.

For patients with BKIs, both unilateral nephrectomy and RAE carry a higher risk of long-term CKD than conservative management alone, as well the potential need for lifelong dialysis; however, the risks are lower for RAE than unilateral nephrectomy. Clinicians should aim to enhance survival and long-term renal outcomes when managing individuals with BKI in accordance with current practice guidelines.

Supplementary Material

zrag051_Supplementary_Data

Acknowledgements

The authors thank Alfred Hsing-Fen Lin and Harrison Ping-Hsiu Tsai, from Raising Statistics Consultant Inc., for their assistance with the statistical analysis.

Contributor Information

Jhih-Ming Tang, Division of Trauma and Emergency Surgery, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan.

Ling-Wei Kuo, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Jen-Fu Huang, Division of Trauma and Emergency Surgery, Jen-Ai Hospital, Dali Branch, Taichung, Taiwan; Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chih-Po Hsu, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chi-Tung Cheng, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Huan-Wu Chen, School of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Emergency and Critical Care Radiology, Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

Cheng-Hsien Wu, School of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Emergency and Critical Care Radiology, Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

Yon-Cheong Wong, School of Medicine, Chang Gung University, Taoyuan, Taiwan; Division of Emergency and Critical Care Radiology, Department of Medical Imaging and Intervention, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.

Szu-An Chen, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chia-Cheng Wang, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Yu-San Tee, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chun-Hsiang Ou Yang, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chih-Yuan Fu, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Chien-Hung Liao, Division of Trauma and Emergency Surgery, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan; School of Medicine, Chang Gung University, Taoyuan, Taiwan.

Funding

This work was supported by the Jen-Ai Hospital, Jen-Ai Medical Foundation, Taichung, Taiwan (Grant No. JMRPGJQ0141 to J.-F.H.), which funded the acquisition of the data set and the subsequent analysis.

Author contributions

Jhih-Ming Tang (Conceptualization, Writing—original draft), Ling-Wei Kuo (Data curation, Methodology), Jenfu Huang (Conceptualization, Writing—review & editing), Chih-Po Hsu (Formal analysis, Software), Chi-Tung Cheng (Resources, Validation), Huan-Wu Chen (Conceptualization), Cheng-Hsien Wu (Methodology), Yon-Cheong Wong (Supervision), Szu-An Chen (Investigation), Chia-Cheng Wang (Formal analysis), Yu-San Tee (Investigation), Chun Hsiang Ouyang (Methodology), Chih-Yuan Fu (Supervision), and Chien-Hung Liao (Project administration)

Disclosure

The authors declare no conflict of interest.

Supplementary material

Supplementary material is available at BJS Open online.

Data availability

The data that support the findings of this study were obtained from the National Health Insurance Research Database in Taiwan. Restrictions apply to the availability of these data, which were used under licence for the present study and are not publicly available.

References

  • 1. Aragona  F, Pepe  P, Patanè  D, Malfa  P, D’Arrigo  L, Pennisi  M. Management of severe blunt renal trauma in adult patients: a 10-year retrospective review from an emergency hospital. BJU Int  2012;110:744–748 [DOI] [PubMed] [Google Scholar]
  • 2. van der Vlies  CH, Olthof  DC, van Delden  OM, Ponsen  KJ, de la Rosette  JJMCH, de Reijke  TM  et al.  Management of blunt renal injury in a level 1 trauma centre in view of the European guidelines. Injury  2012;43:1816–1820 [DOI] [PubMed] [Google Scholar]
  • 3. Terrier  J-E, Paparel  P, Gadegbeku  B, Ruffion  A, Jenkins  LC, N’Diaye  A. Genitourinary injuries after traffic accidents: analysis of a registry of 162,690 victims. J Trauma Acute Care Surg  2017;82:1087–1093 [DOI] [PubMed] [Google Scholar]
  • 4. Veeratterapillay  R, Fuge  O, Haslam  P, Harding  C, Thorpe  A. Renal trauma. J Clin Urol  2017;10:379–390 [Google Scholar]
  • 5. Petrone  P, Perez-Calvo  J, Brathwaite  CEM, Islam  S, Joseph  DK. Traumatic kidney injuries: a systematic review and meta-analysis. Int J Surg  2020;74:13–21 [DOI] [PubMed] [Google Scholar]
  • 6. Herschorn  S, Radomski  SB, Shoskes  DA, Mahoney  J, Hirshberg  E, Klotz  L. Evaluation and treatment of blunt renal trauma. J Urol  1991;146:274–276 [DOI] [PubMed] [Google Scholar]
  • 7. Saidi  A, Descotes  J-L, Sengel  C, Terrier  N, Manel  A, Moalic  R  et al.  Management of blunt trauma of the kidney. Prog Urol  2004;14:461–471 [PubMed] [Google Scholar]
  • 8. Brandes  SB, McAninch  JW. Renal trauma: a practical guide to evaluation and management. ScientificWorldJournal  2004;4:31–40 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Sargent  JC, Marquardt  CR. Renal injuries. J Urol  1950;63:1–8 [DOI] [PubMed] [Google Scholar]
  • 10. McGahan  JP, Rose  J, Coates  TL, Wisner  DH, Newberry  P. Use of ultrasonography in the patient with acute abdominal trauma. J Ultrasound Med. 1997;16:653–662 [DOI] [PubMed] [Google Scholar]
  • 11. Santucci  RA, Bartley  JM. Urologic trauma guidelines: a 21st century update. Nat Rev Urol  2010;7:510–519 [DOI] [PubMed] [Google Scholar]
  • 12. Hardee  MJ, Lowrance  W, Stevens  MH, Nirula  R, Brant  WO, Morris  SE  et al.  Process improvement in trauma: compliance with recommended imaging evaluation in the diagnosis of high-grade renal injuries. J Trauma Acute Care Surg  2013;74:558–562 [DOI] [PubMed] [Google Scholar]
  • 13. Serafetinidis  E, Campos-Juanatey  F, Hallscheidt  P, Mahmud  H, Mayer  E, Schouten  N  et al.  Summary paper of the updated 2023 European Association of Urology guidelines on urological trauma. Eur Urol Focus  2024;10:475–485 [DOI] [PubMed] [Google Scholar]
  • 14. Morey  AF, Broghammer  JA, Hollowell  CMP, McKibben  MJ, Souter  L. Urotrauma guideline 2020: AUA guideline. J Urol  2021;205:30–35 [DOI] [PubMed] [Google Scholar]
  • 15. Buckley  JC, McAninch  JW. Revision of current American Association for the Surgery of Trauma Renal Injury grading system. J Trauma  2011;70:35–37 [DOI] [PubMed] [Google Scholar]
  • 16. Bjurlin  MA, Fantus  RJ, Fantus  RJ, Villines  D. Comparison of nonoperative and surgical management of renal trauma: can we predict when nonoperative management fails?  J Trauma Acute Care Surg  2017;82:356–361 [DOI] [PubMed] [Google Scholar]
  • 17. Nash  PA, Bruce  JE, McAninch  JW, Corriere  J. Nephrectomy for traumatic renal injuries. J Urol  1995;153:609–611 [DOI] [PubMed] [Google Scholar]
  • 18. Dobrowolski  Z, Kusionowicz  J, Drewniak  T, Habrat  W, Lipczyñski  W, Jakubik  P  et al.  Renal and ureteric trauma: diagnosis and management in Poland. BJU Int  2002;89:748–751 [DOI] [PubMed] [Google Scholar]
  • 19. Prasad  NH, Devraj  R, Chandriah  GR, Sagar  SV, Reddy  CR, Murthy  PVLN. Predictors of nephrectomy in high grade blunt renal trauma patients treated primarily with conservative intent. Indian J Urol  2014;30:158–160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Nakao  S, Katayama  Y, Hirayama  A, Hirose  T, Ishida  K, Umemura  Y  et al.  Trends and outcomes of blunt renal trauma management: a nationwide cohort study in Japan. World J Emerg Surg  2020;15:50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Colaco  M, Navarrete  RA, MacDonald  SM, Stitzel  JD, Terlecki  RP. Nationwide procedural trends for renal trauma management. Ann Surg  2019;269:367–369 [DOI] [PubMed] [Google Scholar]
  • 22. Fiard  G, Rambeaud  J-J, Descotes  J-L, Boillot  B, Terrier  N, Thuillier  C  et al.  Long-term renal function assessment with dimercapto-succinic acid scintigraphy after conservative treatment of major renal trauma. J Urol  2012;187:1306–1309 [DOI] [PubMed] [Google Scholar]
  • 23. Lanchon  C, Fiard  G, Arnoux  V, Descotes  J-L, Rambeaud  J-J, Terrier  N  et al.  High grade blunt renal trauma: predictors of surgery and long-term outcomes of conservative management. A prospective single center study. J Urol  2016;195:106–111 [DOI] [PubMed] [Google Scholar]
  • 24. Overs  C, Teklali  Y, Boillot  B, Poncet  D, Rabattu  P-Y, Robert  Y  et al.  Evaluation of the management of severe trauma kidney injury and long-term renal function in children. J Trauma Acute Care Surg  2018;84:951–955 [DOI] [PubMed] [Google Scholar]
  • 25. Wang  S-Y, Lin  K-J, Chen  S-W, Cheng  C-T, Chang  C-H, Wu  Y-T  et al.  Long-term renal outcomes in patients with traumatic renal injury after nephrectomy: a nationwide cohort study. Int J Surg  2019;65:140–146 [DOI] [PubMed] [Google Scholar]
  • 26. Huang  J-F, Liao  C-H, Chen  S-A, Hsu  C-P, Cheng  C-T, Fu  C-Y  et al.  The effect of transarterial embolization and nephrectomy on acute kidney injury in patients with blunt renal trauma: an American College of Surgeons—Trauma Quality Improvement Program analysis. Injury  2024;55:111188 [DOI] [PubMed] [Google Scholar]
  • 27. Chatziioannou  A, Brountzos  E, Primetis  E, Malagari  K, Sofocleous  C, Mourikis  D  et al.  Effects of superselective embolization for renal vascular injuries on renal parenchyma and function. Eur J Vasc Endovasc Surg  2004;28:201–206 [DOI] [PubMed] [Google Scholar]
  • 28. Poulakis  V, Ferakis  N, Becht  E, Deliveliotis  C, Duex  M. Treatment of renal-vascular injury by transcatheter embolization: immediate and long-term effects on renal function. J Endourol  2006;20:405–409 [DOI] [PubMed] [Google Scholar]
  • 29. Mohsen  T, El-Assmy  A, El-Diasty  T. Long-term functional and morphological effects of transcatheter arterial embolization of traumatic renal vascular injury. BJU Int  2008;101:473–477 [DOI] [PubMed] [Google Scholar]
  • 30. Morita  S, Inokuchi  S, Tsuji  T, Fukushima  T, Higami  S, Yamagiwa  T  et al.  Arterial embolization in patients with grade-4 blunt renal trauma: evaluation of the glomerular filtration rates by dynamic scintigraphy with 99mtechnetium-diethylene triamine pentacetic acid. Scand J Trauma Resusc Emerg Med  2010;18:11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Stewart  AF, Brewer  ME  Jr, Daley  BJ, Klein  FA, Kim  ED. Intermediate-term follow-up of patients treated with percutaneous embolization for grade 5 blunt renal trauma. J Trauma  2010;69:468–470 [DOI] [PubMed] [Google Scholar]
  • 32. Collins  CS, Eggert  CH, Stanson  AJ, Garovic  VD. Long-term follow-up of renal function and blood pressure after selective renal arterial embolization. Perspect Vasc Surg Endovasc Ther  2010;22:254–260 [DOI] [PubMed] [Google Scholar]
  • 33. Hsing  AW, Ioannidis  JPA. Nationwide population science: lessons from the Taiwan National Health Insurance Research Database. JAMA Intern Med  2015;175:1527–1529 [DOI] [PubMed] [Google Scholar]
  • 34. Lin  L-Y, Warren-Gash  C, Smeeth  L, Chen  P-C. Data resource profile: the National Health Insurance Research Database (NHIRD). Epidemiol Health  2018;40:e2018062 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Hsieh  C-Y, Su  C-C, Shao  S-C, Sung  S-F, Lin  S-J, Kao Yang  Y-H  et al.  Taiwan’s National Health Insurance Research Database: past and future. Clin Epidemiol  2019;11:349–358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Dupuis  D, Ouellet  G, Roy  L. Retrospective analysis of the predictive factors of renal function loss after uninephrectomy in patients with chronic kidney disease G3 to G5. Can J Kidney Health Dis  2015;2:52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Schleef  M, Roy  P, Lemoine  S, Paparel  P, Colombel  M, Badet  L  et al.  Renal and major clinical outcomes and their determinants after nephrectomy in patients with pre-existing chronic kidney disease: a retrospective cohort study. PLoS One  2024;19:e0300367 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Huang  J-F, Kuo  L-W, Hsu  C-P, Cheng  C-T, Chan  S-Y, Li  P-H  et al. Long-term follow-up of infection, malignancy, thromboembolism, and all-cause mortality risks after splenic artery embolization for blunt splenic injury: comparison with splenectomy and conservative management. BJS Open  2025;9:zraf037 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Cao  J, Wang  T, Li  Z, Liu  G, Liu  Y, Zhu  C  et al.  Factors associated with death in bedridden patients in China: a longitudinal study. PLoS One  2020;15:e0228423 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Vettoretti  S, Caldiroli  L, Zanoni  F, Azzini  V, Villarini  A, Meazza  R  et al.  Patients with hypertensive nephropathy and chronic kidney disease might not benefit from strict blood pressure control. Kidney Blood Press Res  2018;43:1706–1715 [DOI] [PubMed] [Google Scholar]
  • 41. Lee  JY, Park  JT, Joo  YS, Lee  C, Yun  H-R, Yoo  T-H  et al.  Association of blood pressure with the progression of CKD: findings from KNOW-CKD study. Am J Kidney Dis  2021;78:236–245 [DOI] [PubMed] [Google Scholar]
  • 42. Wu  C-S, Lai  M-S, Gau  SS-F, Wang  S-C, Tsai  H-J. Concordance between patient self-reports and claims data on clinical diagnoses, medication use, and health system utilization in Taiwan. PLoS One  2014;9:e112257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Leszczensky  L, Wolbring  T. How to deal with reverse causality using panel data? Recommendations for researchers based on a simulation study. Sociol Methods Res  2022;51:837–865 [Google Scholar]
  • 44. Awdishu  L, Maxson  R, Gratt  C, Rubenzik  T, Battistella  M. KDIGO 2024 clinical practice guideline on evaluation and management of chronic kidney disease: a primer on what pharmacists need to know. Am J Health Syst Pharm  2025;82:660–671 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Shih  C-J, Chen  Y-T, Ou  S-M, Yang  W-C, Kuo  S-C, Tarng  D-C  et al.  The impact of dialysis therapy on older patients with advanced chronic kidney disease: a nationwide population-based study. BMC Med  2014;12:169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. McCaffrey  DF, Griffin  BA, Almirall  D, Slaughter  ME, Ramchand  R, Burgette  LF. A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med  2013;32:3388–3414 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47. Anderson  CF, Velosa  JA, Frohnert  PP, Torres  VE, Offord  KP, Vogel  JP  et al.  The risks of unilateral nephrectomy: status of kidney donors 10 to 20 years postoperatively. Mayo Clin Proc  1985;60:367–374 [DOI] [PubMed] [Google Scholar]
  • 48. Williams  SL, Oler  J, Jorkasky  DK. Long-term renal function in kidney donors: a comparison of donors and their siblings. Ann Intern Med  1986;105:1–8 [DOI] [PubMed] [Google Scholar]
  • 49. Higashihara  E, Horie  S, Takeuchi  T, Nutahara  K, Aso  Y. Long-term consequence of nephrectomy. J Urol  1990;143:239–243 [DOI] [PubMed] [Google Scholar]
  • 50. Buccianti  G, Lorenz  M, Cresseri  D, Bianchi  ML, Valenti  G, Cicchetti  F  et al.  Unilateral nephrectomy and progression of renal failure. Ren Fail  1993;15:415–420 [DOI] [PubMed] [Google Scholar]
  • 51. Baudoin  P, Provoost  AP, Molenaar  JC. Renal function up to 50 years after unilateral nephrectomy in childhood. Am J Kidney Dis  1993;21:603–611 [DOI] [PubMed] [Google Scholar]
  • 52. Goldfarb  DA, Matin  SF, Braun  WE, Schreiber  MJ, Mastroianni  B, Papajcik  D  et al.  Renal outcome 25 years after donor nephrectomy. J Urol  2001;166:2043–2047 [PubMed] [Google Scholar]
  • 53. Lee  YP, Kim  SJ, Lee  J, Lee  JG, Huh  KH, Joo  DJ  et al.  Long-term compensation of renal function after donor nephrectomy. Korean J Transplant  2020;34:84–91 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Cozzi  DA, Ceccanti  S, Cozzi  F. Renal function up to the 5th decade of life after nephrectomy in childhood: a literature review. Nephrology  2018;23:397–404 [DOI] [PubMed] [Google Scholar]
  • 55. Brenner  BM. Nephron adaptation to renal injury or ablation. Am J Physiol Renal Physiol  1985;249:F324–F337 [DOI] [PubMed] [Google Scholar]
  • 56. Hostetter  TH, Olson  JL, Rennke  HG, Venkatachalam  MA, Brenner  BM. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol Renal Physiol  1981;241:F85–F93 [DOI] [PubMed] [Google Scholar]
  • 57. Weight  CJ, Larson  BT, Fergany  AF, Gao  T, Lane  BR, Campbell  SC  et al.  Nephrectomy induced chronic renal insufficiency is associated with increased risk of cardiovascular death and death from any cause in patients with localized cT1b renal masses. J Urol  2010;183:1317–1323 [DOI] [PubMed] [Google Scholar]
  • 58. Mafham  M, Emberson  J, Landray  MJ, Wen  C-P, Baigent  C. Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis. PLoS One  2011;6:e25920 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Donfrancesco  C, Palleschi  S, Palmieri  L, Rossi  B, Lo Noce  C, Pannozzo  F  et al.  Estimated glomerular filtration rate, all-cause mortality and cardiovascular diseases incidence in a low risk population: the MATISS study. PLoS One  2013;8:e78475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Toyama  T, Kitagawa  K, Oshima  M, Kitajima  S, Hara  A, Iwata  Y  et al.  Age differences in the relationships between risk factors and loss of kidney function: a general population cohort study. BMC Nephrol  2020;21:477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. van der Burgh  AC, Rizopoulos  D, Ikram  MA, Hoorn  EJ, Chaker  L. Determinants of the evolution of kidney function with age. Kidney Int Rep  2021;6:3054–3063 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

zrag051_Supplementary_Data

Data Availability Statement

The data that support the findings of this study were obtained from the National Health Insurance Research Database in Taiwan. Restrictions apply to the availability of these data, which were used under licence for the present study and are not publicly available.


Articles from BJS Open are provided here courtesy of Oxford University Press

RESOURCES